Tuberculosis and Diabetes in India: Stakeholder Perspectives on Health System Challenges and Opportunities for Integrated Care.
Muhammed Shaffi Fazaludeen KoyaJinbert LordsonSalman KhanBinod KumarChitra GraceK Rajasekharan NayarVinod KumarAnand M PillaiLal S SadasivanA Marthanda PillaiAbu S AbdullahPublished in: Journal of epidemiology and global health (2022)
Bi-directional screening and management of TB/DM comorbidities in India requires substantial investment in human resources, infrastructure, drug availability, and data infrastructure.
Keyphrases
- mycobacterium tuberculosis
- endothelial cells
- type diabetes
- glycemic control
- healthcare
- cardiovascular disease
- palliative care
- electronic health record
- adverse drug
- induced pluripotent stem cells
- quality improvement
- pulmonary tuberculosis
- hiv aids
- pluripotent stem cells
- machine learning
- metabolic syndrome
- skeletal muscle
- drug induced
- hepatitis c virus
- weight loss
- data analysis